SCHEMBL4244244

SCHEMBL4244244

Cc1ccc2c(c1)c(C(=O)Cl)cn2-c1ccnc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 5/20 0.45
KDR P35968 1/20 0.39
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
MALT1 Q9UDY8 1/20 0.38
AR P10275 1/20 0.37
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.36
AHR P35869 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGS1 P23219 1/20 0.35
RORA P35398 1/20 0.35
NR2E1 Q9Y466 1/20 0.35
NTSR1 P30989 1/20 0.35
ADRB2 P07550 1/20 0.34
NCF1 P14598 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4235822 0.99 PTGDR2 (0.44) PTGDR2KDRHTR2CHTR2BMALT1
SCHEMBL4236274 0.90 PTGDR2 (0.48) PTGDR2KDRHTR2CHTR2BAR
SCHEMBL4236288 0.87 NR4A2 (0.47) PTGDR2KDRMEN1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL4239887 0.86 KCNH2 (0.40) KCNH2MEN1KMT2ASMN1; SMN2NTSR1
SCHEMBL4238424 0.86 RORC (0.39) PTGDR2MALT1ARKCNH2MEN1
Hydrochloric Acid SCHEMBL4242731 0.86 ADRB2 (0.39) PTGDR2ARMEN1KMT2ASMN1; SMN2
SCHEMBL8349128 0.84 SLC9A1 (0.49) PTGDR2KDRHTR2CHTR2BMALT1
SCHEMBL4241847 0.82 PTGDR2 (0.41) PTGDR2KDRHTR2CHTR2BMALT1
Hydrochloric Acid SCHEMBL4241861 0.81 PTGDR2 (0.40) PTGDR2KDRHTR2CHTR2BMALT1
SCHEMBL4235835 0.81 LMNA (0.44) PTGDR2AHRKMT2AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531663-B2 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-05-12 US disclosed
US-20050026989-A1 3-Guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026989-A1 3-Guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them IDO1, IDO2, HTR3C PTGDR2 1004/4885KDR 3193/4885HTR2C 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.